HOME PAGE

 

Sustainable Development

The Solvay group fully recognizes and accepts the Sustainable Development challenge
- Sustainability commitment
Corporate Social Responsibility
REACH legislation

More 

Innovation

The role of Innovation is to be a driver
of Solvay’s sustainable and profitable growth

- New Business Development
Applied Innovation
   

More 

Worldwide presence

More 

All Solvay websites

 Investor Relations
 Press Office 
 Solvay live Group magazine

All Solvay websites 

 
 
  News & Press releases
November 17, 2008
Solvay Pharmaceuticals discontinues R&D activities of its anti-obesity compound SLV319
Solvay Pharmaceuticals announced today its decision to discontinue all R&D activities for its investigational compound SLV319.
[EN]-[FR]-[NL]
   
November 13, 2008
SOLVAY GROUP HOLDS 95.33% OF INNOGENETICS SHARES
Solvay will proceed with squeeze-out of remaining Innogenetics shares and request delisting.
[EN]-[FR]-[NL]
   
 20-11-2008 17:35 
57.52€ -1.01€

accueil
© Solvay S.A • Important information : Privacy Policy  -  Disclaimer • If you have any comments, please contact the webmaster
Date of last update: 17/11/2008